Immunotherapy using purified protein derivative in the treatment of warts: An open uncontrolled trial | Zendy

Vikrant Saoji | Zendy; Nitin Lade | Zendy; Rutuja Gadegone | Zendy; Arun Bhat | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Immunotherapy using purified protein derivative in the treatment of warts: An open uncontrolled trial

Author(s) -

Vikrant Saoji,

Nitin Lade,

Rutuja Gadegone,

Arun Bhat

Publication year - 2015

Publication title -

indian journal of dermatology venereology and leprology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.514

H-Index - 45

eISSN - 0973-3922

pISSN - 0378-6323

DOI - 10.4103/0378-6323.171650

Subject(s) - medicine , purified protein derivative , verruca vulgaris , dermatology , erythema , immunotherapy , surgery , open label , plantar warts , adverse effect , tuberculin , randomized controlled trial , tuberculosis , immunology , immune system , pathology

Warts are known to clear spontaneously with the development of cell-mediated immunity (CMI) to the virus. Purified protein derivative (PPD) of tuberculin bacilli has been used as a non-specific stimulant of CMI to achieve this outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research